Volbeat sets US chart record 

Danish rockers pip U2 for their eighth Billboard number one hit

The Danish rock band Volbeat has managed to secure a serious foothold on the US market.  

In fact, the band has set a new record for a non-US artist with its eighth number one hit on the Billboard hit list – which ranks the most-played tunes on the radio within its genre. 

It’s the first time a non-US band has reached number one on the list for the eighth time – the previous record holder being none other than U2, which has done so seven times since 1981.  


The 
Volbeat song topping the charts at the moment is ‘Die to live’ off the ‘Rewind, Replay, Rebound’ album, which was released last year. 

However, the Danes have their work cut out if they want to reach the all-time record for US bands. 

Shinedown and Three Days Grace have both had number-one hits no less than 15 times.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.